Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Alkermes plc today will present an overview of its proprietary pipeline portfolio at its Research and Development (R&D) Day meeting for analysts and investors. For the first time, the company will discuss three new drug candidates including: a ...
read more
Alkermes plc today announced that it has expanded its senior management team by appointing two industry veterans to newly created roles. Srdjan (Serge) Stankovic, M.D., MSPH, will serve as Senior Vice President of Clinical Development and Medical ...
read more
Wednesday, April 17, 2013
Alkermes plc (NASDAQ: ALKS) today announced positive preliminary topline results from a phase 2 study of ALKS 5461, its novel drug compound for major depressive disorder (MDD) in patients who have an inadequate response to standard therapies for ...
read more
Tuesday, January 07, 2014
Alkermes plc (NASDAQ:ALKS) today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application 14/032,736, entitled “Prodrugs of fumarates and their use in treating various diseases....
read more
Monday, September 21, 2020
Alimera Sciences Europe has signed a distribution agreement with Medis for the exclusive sales and distribution of ILUVIEN in the Czech Republic and Austria.
read more
PCI Synthesis, Inc. (www.pcisynthesis.com), a 12-year-old custom chemical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical products, today announced that industry veteran ...
read more
Aleafia Health’s indirect subsidiary, Emblem Germany GmbH, has formally submitted its application to German regulators for EU Good Manufacturing Practices (EU-GMP) certification.
read more
Tuesday, December 12, 2017
Aldevron announced a license agreement whereby Aldevron will manufacture and distribute a S. pyogenes Cas9 variant which is patented by IDT.
read more
Aldevron has announced expansion plans for a 14-acre campus at its headquarters in Fargo, N.D.
read more
Don Kania, Ph.D., has been appointed to the Board of Directors of Aldevron, a global provider of plasmid DNA manufacturing, protein production and antibody discovery services.
read more
Aldevron, has successfully completed the manufacturing of the TUSC2 plasmid DNA pursuant to the manufacturing agreement between Genprex and Aldevron that was announced in September 2018.
read more
Aldevron has hired Vijay Surapaneni as its Vice President of Biomanufacturing Operations. This is a new position and is a part of the senior management team.
read more
Aldevron announced its new fermentation capacity of 1,000 liters and plans to increase the Company’s manufacturing footprint in Madison, WI.
read more
Alcami and the UNCW have been awarded an educational grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals.
read more
Alcami announces the Missouri House of Representatives and St. Louis Mayor Lyda Krewson will honor Alcami with a resolution and letter of commendation.
read more